Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2023-11-16 00:00:00 ET · period of report 2023-11-14 · accession 0001104659-23-119188 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-16 | 2023-11-14 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $1.70 | +1.57M | 2.60M | +152% | +$2.66M |
| D | 2023-11-16 | 2023-11-14 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $0.00 | +1.57M | 1.57M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.001 | 2023-11-14 | P | A | 1,567,515 | $1.70 | 2,597,440 | D | — | — | (F1) Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. (F2) The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70. |
| 2 | Derivative | Warrants to purchase Common Stock | 2023-11-14 | P | A | 1,567,515 | $0.00 | 1,567,515 | D | $1.70 · 2023-11-14 to 2028-11-14 | 1,567,515 Common Stock | (F2) The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70. |